# A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants

> **NCT07655518** · PHASE1 · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 12 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986521

## Key facts

- **NCT ID:** NCT07655518
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2026-12-27
- **Final completion:** 2026-12-27
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655518, "A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*